Botulinum Toxin and Related Neurological Disorders

Botulinum toxin, produced by the bacterium *Clostridium botulinum*, is one of the most potent biological substances known, yet controlled clinical doses have become a cornerstone treatment for conditions ranging from post-stroke spasticity to chronic pain, where it works by blocking the release of acetylcholine at neuromuscular junctions through highly specific protein receptor interactions. Researchers study both its underlying mechanisms — how it cleaves the molecular machinery that nerves use to signal muscles — and its expanding therapeutic applications across neurological disorders where muscle overactivity or aberrant signaling causes lasting disability. Active areas of investigation include refining dosing protocols to extend the duration of effect and reduce patient burden, as well as understanding why some individuals develop resistance to the toxin over time. There is

Works

81,556

Total citations

909,694

Keywords

Botulinum ToxinNeurotoxinsSpasticityStrokeNeurological DisordersPain Management